Results 261 to 270 of about 2,744,319 (336)

CD3ɛ Nanobody‐Engineered Extracellular Vesicles Driving In Vivo Generation of BiTE‐Secreting CAR‐Ts for Solid Tumor Therapy With Memory Response and Minimal Immunogenicity

open access: yesAdvanced Science, EarlyView.
HEK‐293T‐derived CD3ε Nb‐engineered EVs to generate dual‐targeting CAR‐T cells directly in vivo. These EVs selectively deliver CAR.BiTE transgenes into T cells and reprogramed to HLA‐G/PD‐L1‐targeting effector cells with enhanced memory and persistence.
Shi‐Wei Huang   +27 more
wiley   +1 more source

Cellular Identity Crisis: RD3 Loss Fuels Plasticity and Immune Silence in Progressive Neuroblastoma

open access: yesAdvanced Science, EarlyView.
Researchers discovered that therapy‐induced loss of RD3 protein in neuroblastoma triggers a dangerous shift: cancer cells become more stem‐like, invasive, and resistant to treatment while evading immune detection. RD3 loss suppresses antigen presentation and boosts immune checkpoints, creating an immune‐silent environment.
Poorvi Subramanian   +7 more
wiley   +1 more source

Cryo-EM snapshots of NMDA receptor activation illuminate sequential rearrangements. [PDF]

open access: yesSci Adv
Abbott JA   +5 more
europepmc   +1 more source

Dynamics and Interplay of the Binding Pockets in the Glycine Receptor. [PDF]

open access: yesJ Chem Inf Model
Xue G   +4 more
europepmc   +1 more source

Epitope analysis of an anti-mouse CCR1 monoclonal antibody S15040E using flow cytometry. [PDF]

open access: yesBiochem Biophys Rep
Okada A   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy